Antibody Choice Alters Breast Cancer Subtyping
October 10, 2025
By Kathryn Wighton
Researchers compared MIB1 and SP6 antibodies for Ki-67 assessment in breast carcinoma.
1 min read
False
Research, trends, news, and views
October 10, 2025
By Kathryn Wighton
Researchers compared MIB1 and SP6 antibodies for Ki-67 assessment in breast carcinoma.
1 min read
October 7, 2025
By Helen Bristow
AI-powered test enhances progression risk assessment in esophageal cancer
5 min read
October 3, 2025
Researchers show that p63 expression occurs in most high-grade invasive breast carcinomas.
2 min read
September 30, 2025
By Jessica Allerton
Following a new CAP review, Jason L. Hornick discusses the strengths – and limitations – of IHC as a stand-in for molecular testing
4 min read
September 30, 2025
SPARC, an extracellular matrix protein, is identified as prognostic marker in interstitial lung diseases, including unclassifiable cases
2 min read
September 25, 2025
Consensus recommendations standardize homologous recombination deficiency testing for clinical molecular laboratories
2 min read
September 24, 2025
By Kathryn Wighton
Keratin 15–driven mouse model shows diverse tumor types and suggests that tumors with PI3K mutations may respond to the drug alpelisib.
2 min read
September 23, 2025
TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples...
12:00 pm - 1:00 pm GMT-4 min read
September 22, 2025
By Kathryn Wighton
Copper, ceruloplasmin, and fibrosis pathways mapped in patients and knockout mice reveal diagnostic insights for Wilson disease
2 min read
September 18, 2025
By Helen Bristow
With millions of contextualized patient data records now available across oncology, clinical development needs to evolve for the precision medicine era, says Gen Li
6 min read
False
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False